Showing results (21-30 of 925) with videos related to
Sort By:
Pageof 93
Journal of Breast Cancer|October 17, 2015
Association between Metformin Therapy and Breast Cancer Incidence and Mortality: Evidence from a Meta-AnalysisTing Yang, Yuan Yang, Shengchun LiuScientific Reports|November 25, 2025
Research on precise estimation of line loss rate probability density based on bilateral total variation filtering algorithmJie Zhang, Shengchun Liu, Chao FengJournal of Immunology Research|June 13, 2022
Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast CancerYingkun Xu, Dan Shu, Meiying Shen, et al.Journal of Oncology|May 2, 2022
Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer PatientsYingkun Xu, Yang Peng, Meiying Shen, et al.Biomed Research International|September 9, 2022
Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-CancerYingkun Xu, Meiying Shen, Yang Peng, et al.Oncology Reports|July 23, 2021
[Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage toleranceBeige Zong, Lu Sun, Yang Peng, et al.Journal of Personalized Medicine|February 25, 2023
Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant ChemotherapyAilin Lan, Han Li, Junru Chen, et al.Frontiers in Surgery|September 19, 2022
Association of serum reproductive hormones changes after neoadjuvant chemotherapy with hormone receptors expression alterations and survival outcomes in breast cancerAilin Lan, Yudi Jin, Yu Wang, et al.International Journal of Clinical Oncology|March 3, 2022
Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapyAilin Lan, Yudi Jin, Yu Wang, et al.Oncology Reports|May 26, 2021
HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage toleranceBeige Zong, Lu Sun, Yang Peng, et al.Pageof 93